$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Entrectinib detailed instructions
2026-02-01 22:25:32
Check Details
How many months can I usually take entrectinib?
2026-02-01 22:25:32
Check Details
How much does entrectinib cost? How much does an individual pay after medical insurance reimbursement?
2026-02-01 22:25:32
Check Details
What is acalatinib/acatinib?
2026-02-01 22:25:32
Check Details
First-line Tamibarotene combined with Venetoclax and azacitidine induces 100% CR rate in SELECT-AML-1 trial
2026-02-01 22:25:32
Check Details
MRD-guided ibrutinib/Venetoclax brings PFS benefit in CLL
2026-02-01 22:25:32
Check Details
What is the required concentration of venetoclax/venetoclax?
2026-02-01 22:25:32
Check Details
Can venetoclax/venetoclax be used long-term?
2026-02-01 22:25:32
Check Details
Is Venetoclax/Venetoclax better to be domestically produced or imported?
2026-02-01 22:25:32
Check Details
Is venetoclax/venetoclax a targeted drug or a chemotherapy drug?
2026-02-01 22:25:32
Check Details
What are the side effects of venetoclax/venetoclax and how long do they last?
2026-02-01 22:25:32
Check Details
Can I be reimbursed for Venetoclax/Venetoclax? What is the price after medical insurance?
2026-02-01 22:25:32
Check Details
1
2
...
502
503
504
505
506
507
508
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
2
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
3
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
4
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
5
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
6
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
7
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
8
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
9
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure
10
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
11
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
12
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review